Russell Alan J. - 11 Oct 2021 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role: Chief Scientific Officer, Director
Signature: /s/ John R. Moore, Attorney-in-Fact for Russell Alan J
Issuer symbol: EWTX
Transactions as of: 11 Oct 2021
Net transactions value: -$22,885
Form type: 4
Filing time: 13 Oct 2021, 18:51:12 UTC
Previous filing: 08 Oct 2021
Next filing: 18 Oct 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EWTX	Common Stock	Sale	$22,885	-1,270	-0.83%	$18.02	151,024	11 Oct 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on June 17, 2021.
F2	The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.18, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on June 17, 2021.

The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.18, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.